UTILISATION DE LA SOUS-UNITE ALPHA 2 DU RECEPTEUR IL-13 COMME VACCIN ANTI-CANCER

• 收藏
• 分享

专利权人:

THE PENN STATE RESEARCH FOUNDATION

发明人:

DEBINSKI, WALDEMAR,CHRISTENSEN, NEIL,MINTZ, AKIVA

申请号：

CA2480008

公开号：

CA2480008C

申请日:

2002.03.22

申请国别(地区):

CA

年份:

2015

代理人:

摘要：

A method for stimulating an immune response against IL-12R.alpha.2 in asubject having or at risk for developing a disease having cells expressing IL-13R.alpha.2 includes the steps of formulating the anti-cancer vaccine outsideof the subject and administering the vaccine to the subject in an amountsufficient to stimulate an immune response against IL-13R.alpha.2 in thesubject. A composition for stimulating an immune response agaist IL-13R.alpha.2 in a subject having or at risk for developing a disease havingcells expressing IL-13R.alpha.2 includes an isolated agent that can stimulateimmune response against IL-13.alpha.2.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/